Another falling on good news!
$Kazia Therapeutics(KZIA.US$ SYDNEY, May 1, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specialising in oncology, is pleased to announce that the Safety Review Team (SRT) of the EVT801 Phase 1 clinical trial has concluded that the primary and secondary objectives of stage 1 of the trial have successfully been met. It shoulda been a weight loss drug making good advancement! It would be climbing then! Hehehe![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Jaguar8 : It might climb later since it’s overweight issue
Stock_Drift : I’m in.
thanks
TrytosaveabitOP Stock_Drift: You’re welcome GL
Mod Tan : they just issue the prospectus, diluting shares again.
TrytosaveabitOP Mod Tan: It’s a amendment to the one filed back in February! May not have much of a affect? Need to finish updated price/amount! GL
Dennis Takizawa Hide TrytosaveabitOP: thanks for informing, I didn't read up but just saw the prospectus
TrytosaveabitOP Dennis Takizawa Hide: You’re very welcome! GL and big profits to ya
Dennis Takizawa Hide TrytosaveabitOP: Thank you and to all of us
TrytosaveabitOP Dennis Takizawa Hide: Absolutely
